Cargando…

Autoimmunity – Multiple Sclerosis

Detalles Bibliográficos
Autores principales:	Ances, Beau M., Newman, Nancy J., Balcer, Laura J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2005
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149882/ http://dx.doi.org/10.1016/B978-012455900-4/50307-X

Ejemplares similares

Eye disorders in patients with multiple sclerosis: natural history and management
por: Graves, Jennifer, et al.
Publicado: (2010)

Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology
por: Calabresi, Peter A., et al.
Publicado: (2010)

Vision and vision-related outcome measures in multiple sclerosis
por: Balcer, Laura J., et al.
Publicado: (2015)

The Role of Autoimmunity in Multiple Sclerosis
por: Bradl, Monika, et al.
Publicado: (2005)

Is Multiple Sclerosis an Autoimmune Disease?
por: Wootla, Bharath, et al.
Publicado: (2012)

Multiple Sclerosis and Autoimmune Comorbidities
por: Nociti, Viviana, et al.
Publicado: (2022)

Virus-mediated autoimmunity in Multiple Sclerosis
por: Grigoriadis, Nikolaos, et al.
Publicado: (2006)

Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life
por: Chahin, Salim, et al.
Publicado: (2015)

Alemtuzumab improves contrast sensitivity in patients with relapsing–remitting multiple sclerosis
por: Graves, Jennifer, et al.
Publicado: (2013)

Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis
por: Schmitz, K., et al.
Publicado: (2017)

Familial multiple sclerosis and association with other autoimmune diseases
por: Pytel, Vanesa, et al.
Publicado: (2017)

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Girolamo, Francesco, et al.
Publicado: (2014)

Multiple Sclerosis and Autoimmunity: A Veiled Relationship
por: Barkhane, Zineb, et al.
Publicado: (2022)

Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference Proceedings
por: Goldschmidt, Carolyn, et al.
Publicado: (2022)

Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Pallais, Jean Pierre, et al.
Publicado: (2019)

Mechanistic underpinning of an inside–out concept for autoimmunity in multiple sclerosis
por: ’t Hart, Bert A., et al.
Publicado: (2021)

Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis
por: Cunningham, Timothy J, et al.
Publicado: (2006)

Autoimmune T-Cell Reactivity to Myelin Proteolipids and Glycolipids in Multiple Sclerosis
por: Greer, Judith M.
Publicado: (2013)

Environmental factors in autoimmune diseases and their role in multiple sclerosis
por: Jörg, Stefanie, et al.
Publicado: (2016)

Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Editorial: Brain-Targeted Autoimmunity: Beyond Multiple Sclerosis
por: Nataf, Serge, et al.
Publicado: (2021)

Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Lovett-Racke, Amy, et al.
Publicado: (2022)

Relapsing experimental allergic encephalomyelitis an autoimmune model of multiple sclerosis
por: Lublin, Fred D.
Publicado: (1985)

Autoimmune Disease Prevalence in a Multiple Sclerosis Cohort in Argentina
por: Farez, Mauricio F., et al.
Publicado: (2014)

Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis
por: Balcer, Laura J, et al.
Publicado: (2017)

Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
por: Perumal, Jai, et al.
Publicado: (2021)

Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis
por: Mey, Gabrielle M., et al.
Publicado: (2022)

Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis
por: Greenberg, Benjamin M., et al.
Publicado: (2021)

The Double-Edged Sword of Autoimmunity: Lessons from Multiple Sclerosis
por: Hestvik, Anne Lise K.
Publicado: (2010)

Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Costanza, Massimo, et al.
Publicado: (2012)

Autoimmune Hepatitis with Multiple Sclerosis and Graves Disease: Coincidence or Association?
por: Nadhem, Omar N., et al.
Publicado: (2014)

Focusing on caveolin-1 in CNS autoimmune disease: multiple sclerosis
por: Wu, Hao, et al.
Publicado: (2016)

Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis
por: Alamo, Angela, et al.
Publicado: (2019)

Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders
por: Brummer, Tobias, et al.
Publicado: (2021)

MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases
por: Mechelli, Rosella, et al.
Publicado: (2021)

Thyroid Autoimmunity Following Alemtuzumab Treatment in Multiple Sclerosis Patients
por: Kazakou, Paraskevi, et al.
Publicado: (2021)

Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE
por: Perumal, Jai, et al.
Publicado: (2019)

Moving Toward Disentangling Heterogeneity in Central Nervous System Complications in People With Human Immunodeficiency Virus
por: Rubin, Leah H, et al.
Publicado: (2023)

Co-occurrence of autoimmune thyroid disease in a multiple sclerosis cohort
por: Sloka, JS, et al.
Publicado: (2005)

Correction to: Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
por: Perumal, Jai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ec77im1v07orhcv425gq5o3fk